IP Library Granted Patent US 12,433,751
Granted Patent B2
US 12,433,751 · App. 18/360,005 · Granted Oct 7, 2025

Orthopaedic implant systems including internal networks and methods of repair

Inventors: Nick Metcalfe (Bonita Springs, FL); Reinhold Schmieding (Naples, FL); Michael Moreland (Fort Myers, FL); Steven Jim DeLeon (Naples, FL); David Knopf (Bonita Springs, FL); Scott William Doody (Bonita Springs, FL); Siddhant Thakur (Naples, FL)
Assignee: ARTHREX, INC.
A61F2/30734A61F2/4081A61F2002/30736A61F2002/30769
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,433,751
App. No.
18/360,005
Granted
Oct 7, 2025
Kind
B2
Abstract

This disclosure relates to orthopaedic implant systems and methods for repairing bone defects and restoring functionality to a joint. The implant systems and methods disclosed herein may include augments extending from respective baseplates. The augments may have an internal network for communicating material in the respective implant.

Claims (49)

1. An orthopaedic implant system comprising:

an implant including a baseplate and an augment;

wherein the baseplate includes a plate body extending between front and rear faces, and the front face is configured to face towards an opposed articular surface associated with a bone;

wherein the augment includes an augment body extending from the rear face of the plate body, and the augment body includes a network of internal passages that branch to respective ports along an external surface of the augment body;

wherein the implant includes an interface aperture defined along an external surface of the implant;

wherein the network includes a main trunk, and the internal passages divide from the main trunk into branched paths at respective junctions such that at least two of the junctions are established between the interface aperture and each of the respective ports; and

wherein the implant includes at least one fixation aperture configured to receive a respective fastener to secure the implant to bone, the at least one fixation aperture includes a first section that extends through the plate body and a second section that extends through the augment body.

2. The system as recited in claim 1 , wherein the branched paths split in different directions such that the respective junction has a Y-shaped geometry.

3. The system as recited in claim 1 , wherein the network is dimensioned to branch outwardly from the rear face of the plate body to opposed sidewalls of the augment body.

4. The system as recited in claim 3 , wherein the main trunk extends along an axis that intersects the plate body, and the at least two junctions are offset from the axis.

5. The system as recited in claim 1 , wherein the internal passages interconnect the respective ports and the interface aperture.

6. The system as recited in claim 1 , wherein the network is arranged according to a Fibonacci sequence such that a cross sectional area of the internal passages progressively decreases in a series of the junctions in a direction towards the respective ports.

7. The system as recited in claim 5 , further comprising:

a pump securable to the interface aperture; and

wherein the pump is configured to draw biological material from the ports at least partially into the internal passages.

8. The system as recited in claim 5 , wherein:

the interface aperture is defined along the plate body; and

the main trunk extends outwardly from the interface aperture.

9. The system as recited in claim 1 , further comprising:

a pad including a concave articulation surface; and

wherein the pad is securable to the baseplate adjacent the front face.

10. The system as recited in claim 1 , further comprising:

an articulation head including a convex articulation surface; and

wherein the articulation head is securable to the baseplate adjacent the front face.

11. The system as recited in claim 10 , wherein the articulation head includes a recess dimensioned to at least partially receive the plate body.

12. The system as recited in claim 1 , further comprising:

one or more bioactive layers that establish at least a majority of surfaces of the augment body that define the network.

13. An orthopaedic implant system comprising:

an implant including a baseplate and an augment extending from the baseplate, wherein the baseplate includes a plate body extending between front and rear faces, wherein the front face of the baseplate is configured to face towards an opposed articular surface associated with a bone, and the augment includes an augment body including a network of internal passages coupled to respective ports along an external surface of the augment body; and

a pump configured to draw biological material at least partially into the network;

wherein the implant includes at least one fixation aperture configured to receive a respective fastener to secure the implant to bone, the at least one fixation aperture includes a first section that extends through the plate body and a second section that extends through the augment body.

14. The system as recited in claim 13 , wherein the network is arranged according to a Fibonacci sequence such that a cross sectional area of the internal passages progressively decreases in a series of junctions in a direction from the baseplate towards the respective ports.

15. The system as recited in claim 13 , wherein:

the implant includes an interface aperture defined along an external surface of the implant, and the internal passages interconnect the respective ports and the interface aperture; and

the pump is securable to the implant at the interface aperture.

16. The system as recited in claim 13 , further comprising:

an articulation member including an articulation surface that is configured to cooperate with the opposed articular surface to establish a joint interface; and

wherein the articulation member is securable to the baseplate.

17. The system as recited in claim 16 , further comprising:

a fastener that is receivable in an interface aperture of the implant to secure the articulation member to the implant.

18. The system as recited in claim 13 , further comprising:

a plurality of fasteners; and

wherein the at least one fixation aperture includes a plurality of fixation apertures, and each of the fixation apertures is configured to receive a respective one of the fasteners to secure the implant to bone.

19. The system as recited in claim 1 , wherein:

the at least one fixation aperture includes a plurality of fixation apertures, and the fixation apertures are distributed about the interface aperture.

20. The system as recited in claim 18 , wherein:

the implant includes an interface aperture defined along an external surface of the implant, and the internal passages interconnect the respective ports and the interface aperture;

the pump is securable to the implant at the interface aperture; and

the plurality of fixation apertures are distributed about the interface aperture.

Continuity (2)
Continuation 17221049 · Apr 2, 2021
Related Publication 20230363915A1 · Nov 16, 2023
References Cited (120)
US 4274163A · Malcom · 1981 [cited by examiner]
US 5116377A · Skripitz · 1992 [cited by examiner]
US 5152797A · Luckman · 1992 [cited by examiner]
US 5681289A · Wilcox · 1997 [cited by examiner]
US 5702446A · Schenck · 1997 [cited by examiner]
US 6328765B1 · Hardwick · 2001 [cited by examiner]
US 6455311B1 · Vacanti · 2002 [cited by applicant]
US 6565572B2 · Chappius · 2003 [cited by examiner]
US 6740120B1 · Grimes · 2004 [cited by examiner]
US 6979336B2 · Durniak · 2005 [cited by examiner]
US 7090668B1 · U · 2006 [cited by examiner]
US 7361369B2 · Liebschner · 2008 [cited by examiner]
US 7488320B2 · Middleton · 2009 [cited by examiner]
US 7819925B2 · King et al. · 2010 [cited by applicant]
US 8147558B2 · Lee et al. · 2012 [cited by applicant]
US 8292967B2 · Brown · 2012 [cited by examiner]
US 8303665B2 · Tornier et al. · 2012 [cited by applicant]
US 8500819B2 · Meridew · 2013 [cited by examiner]
US 8632597B2 · Lappin · 2014 [cited by applicant]
US 8764836B2 · DeWilde et al. · 2014 [cited by applicant]
US 8852283B2 · Tornier et al. · 2014 [cited by applicant]
US 8870962B2 · Roche et al. · 2014 [cited by applicant]
US 8940054B2 · Wiley et al. · 2015 [cited by applicant]
US 9005184B2 · Mayer · 2015 [cited by examiner]
US 9066806B2 · Phipps · 2015 [cited by applicant]
US 9095438B1 · Wait · 2015 [cited by examiner]
US 9114017B2 · Lappin · 2015 [cited by applicant]
US 9226830B2 · De Wilde et al. · 2016 [cited by applicant]
US 9233003B2 · Rouche et al. · 2016 [cited by applicant]
US 9283083B2 · Winslow et al. · 2016 [cited by applicant]
US 9289301B2 · Mayer · 2016 [cited by examiner]
US 9351843B2 · Viscogliosi · 2016 [cited by examiner]
US 9452055B2 · Lappin · 2016 [cited by applicant]
US 9532880B2 · Lappin · 2017 [cited by applicant]
US 9545311B2 · Courtney, Jr. et al. · 2017 [cited by applicant]
US 9545312B2 · Tornier et al. · 2017 [cited by applicant]
US 9616205B2 · Nebosky · 2017 [cited by examiner]
US 9629725B2 · Gargac et al. · 2017 [cited by applicant]
US 9844440B2 · Kovacs et al. · 2017 [cited by applicant]
US 9980819B2 · Gray · 2018 [cited by applicant]
US 10010609B2 · D'Agostino et al. · 2018 [cited by applicant]
US 10034757B2 · Kovacs et al. · 2018 [cited by applicant]
US 10251755B2 · Boileau · 2019 [cited by examiner]
US 10258478B2 · Kovacs et al. · 2019 [cited by applicant]
US 10265184B2 · Lappin · 2019 [cited by applicant]
US 10357373B2 · Gargac et al. · 2019 [cited by applicant]
US 10383735B2 · Wiley et al. · 2019 [cited by applicant]
US 10517736B2 · Lappin et al. · 2019 [cited by applicant]
US 10555816B1 · Pappou · 2020 [cited by applicant]
US 10688223B2 · Cui et al. · 2020 [cited by applicant]
US 10709814B2 · Vickers et al. · 2020 [cited by applicant]
US 10722374B2 · Hodorek et al. · 2020 [cited by applicant]
US 20030065397A1 · Hanssen · 2003 [cited by examiner]
US 20040220674A1 · Pria · 2004 [cited by examiner]
US 20040225360A1 · Malone · 2004 [cited by examiner]
US 20050261775A1 · Baum et al. · 2005 [cited by applicant]
US 20050278030A1 · Tornier et al. · 2005 [cited by applicant]
US 20060015188A1 · Grimes · 2006 [cited by applicant]
US 20060100706A1 · Shadduck · 2006 [cited by examiner]
US 20060200248A1 · Beguin et al. · 2006 [cited by applicant]
US 20080119945A1 · Frigg · 2008 [cited by examiner]
US 20090069899A1 · Klein · 2009 [cited by examiner]
US 20100042214A1 · Nebosky et al. · 2010 [cited by applicant]
US 20100087927A1 · Roche · 2010 [cited by examiner]
US 20100222750A1 · Cheng · 2010 [cited by examiner]
US 20110060373A1 · Russell · 2011 [cited by examiner]
US 20120209392A1 · Angibaud · 2012 [cited by examiner]
US 20130211539A1 · McDaniel · 2013 [cited by examiner]
US 20130282131A1 · Anapliotis · 2013 [cited by examiner]
US 20140025173A1 · Cardon et al. · 2014 [cited by applicant]
US 20150250598A1 · Yakimicki · 2015 [cited by examiner]
US 20160317704A9 · Lyngstadaas et al. · 2016 [cited by applicant]
US 20170095336A1 · Tornier et al. · 2017 [cited by applicant]
US 20170216491A1 · Schlachter et al. · 2017 [cited by applicant]
US 20170273801A1 · Hodorek · 2017 [cited by applicant]
US 20180021140A1 · Angelini et al. · 2018 [cited by applicant]
US 20180303618A1 · Kovacs et al. · 2018 [cited by applicant]
US 20180333268A1 · Cardon et al. · 2018 [cited by applicant]
US 20190015116A1 · Gargac et al. · 2019 [cited by applicant]
US 20190015117A1 · Neichel et al. · 2019 [cited by applicant]
US 20190015118A1 · Neichel et al. · 2019 [cited by applicant]
US 20190015221A1 · Neichel et al. · 2019 [cited by applicant]
US 20190151106A1 · Kovacs et al. · 2019 [cited by applicant]
US 20190159907A1 · Roche et al. · 2019 [cited by applicant]
US 20190240035A1 · Lappin · 2019 [cited by applicant]
US 20190298537A1 · Gargac et al. · 2019 [cited by applicant]
US 20190358045A1 · Boileau et al. · 2019 [cited by applicant]
US 20200030108A1 · Orphanos et al. · 2020 [cited by applicant]
US 20200113632A1 · Varadarajan et al. · 2020 [cited by applicant]
US 20200155322A1 · Walker et al. · 2020 [cited by applicant]
US 20200179126A1 · Courtney, Jr. et al. · 2020 [cited by applicant]
US 20200188121A1 · Boux de Casson et al. · 2020 [cited by applicant]
US 20200229931A1 · Tornier et al. · 2020 [cited by applicant]
US 20210022869A1 · Forsell · 2021 [cited by examiner]
US 20210085467A1 · Dietz · 2021 [cited by examiner]
US 20220047392A1 · de Beaubien · 2022 [cited by examiner]
US 20240156608A1 · Bertolotti · 2024 [cited by examiner]
DE 3704089 · 1988 [cited by applicant]
EP 2724691 · 2015 [cited by applicant]
EP 2328511B1 · 2016 [cited by examiner]
EP 3498227 · 2019 [cited by applicant]
EP 3498227A1 · 2019 [cited by examiner]
EP 3763335 · 2021 [cited by applicant]
JP 2000501312 · 2000 [cited by applicant]
JP 2014511226 · 2014 [cited by applicant]
JP 5955818 · 2016 [cited by applicant]
JP 2016522058 · 2016 [cited by applicant]
WO 2008040408 · 2008 [cited by applicant]
WO WO2008040408A1 · 2008 [cited by examiner]
WO WO2012030331A1 · 2012 [cited by examiner]
WO 2017165346 · 2017 [cited by applicant]
WO 2018052965 · 2018 [cited by applicant]
WO 2018081073 · 2018 [cited by applicant]
WO 2018136393 · 2018 [cited by applicant]
International Preliminary Report on Patentability for International Patent Application No. PCT/US2022/020681 mailed Oct. 12, 2023. [cited by applicant]
Musculoskeletal Key. Arthrex Univers Revers (TM) shoulder prosthesis. Retrieve from: https://musculoskeletalkey.com/arthrex-univers-revers-shoulder-prosthesis/. [cited by applicant]
Equinoxe Platform System. Exactech. Retrieved from: https://www.exac.com/extremities/equinoxe-platform-system/. [cited by applicant]
Equionxe strength in numbers. Exactech. Retrieved from: https://www.exac.com/wp-content/uploads/2021/06/12-0000039_Equinoxe_Main_Brochure_Web.pdf. [cited by applicant]
International Search Report for International Application No. PCT/US2022/020681 mailed Jun. 28, 2022. [cited by applicant]
Japanese Office Action for Japanese Application No. 2023-560691 mailed Aug. 5, 2024. [with English translation]. [cited by applicant]